IP Library Granted Patent US 7,235,635
Granted Patent B2
US 7,235,635 · App. 10/990,276 · Granted Jun 26, 2007

IRAK-4: compositions and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,635
App. No.
10/990,276
Granted
Jun 26, 2007
Kind
B2
Abstract

The present invention provides nucleic acids and polypeptides for IRAK-4, a novel member of the IRAK family of protein kinases. Members of the IRAK family are indispensable signal transducer for members of the IL-1R/Toll family of transmembrane receptors, including IL-1 receptors, IL-18 receptors and LPS receptors. IRAK-4 sequences from human and mouse are provided, as are methods for identifying compounds useful in the treatment or prevention of inflammatory diseases.

Claims (3)

1. An isolated IRAK-4 polypeptide comprising the amino acid sequence of SEQ ID NO:1.

2. An isolated IRAK-4 polypeptide comprising the amino acid sequence of SEQ ID NO:1, wherein the polypeptide comprises a substitution of alanine for lysine at residues 213 and 214 of SEQ ID NO:1.

3. An isolated IRAK-4 polypeptide, wherein the polypeptide consists of amino acids 1–191 of SEQ ID NO:1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
MERGER Recorded Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
CHANGE OF NAME Recorded Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →